Skip to main content
Clinical Trials/IRCT201402041760N30
IRCT201402041760N30
Completed
Phase 2

Comparison of GnRH agonists and antagonists the outcome IVF/ICSI in women with polycystic ovary syndrome

Vice Chancellor for Research and Technology, Babol University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Polycystic ovarian syndrome.
Sponsor
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Enrollment
120
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice Chancellor for Research and Technology, Babol University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • PCOs; having two of the three diagnostic criteria Rotterdam 2003(Irregular menstruation oligomenorrhea, amenorrhea and irregular bleeding); hyperandrogenism(Hirsutism, severe acne, hair loss); obesity; polycystic ovaries on ultrasound to rule out specific diseases such as disorders of the hypothalamus, pituitary or other causes hyperandrogenism ; age \= 35 years; FSH \<12 mlu / ml on days 2\-3 of the cycle
  • Exclusion criteria: history of more than two abortions;
  • in laparoscopic uterine anomaly, hysteroscopy \& hysterosonography; ovarian cysts.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials